Zenas BioPharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZBIO and other ETFs, options, and stocks.About ZBIO
Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company, which engages in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O.
CEOLeon Oliver Moulder
CEOLeon Oliver Moulder
Employees130
Employees130
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2019
Founded2019
Employees130
Employees130
ZBIO Key Statistics
Market cap1.41B
Market cap1.41B
Price-Earnings ratio-7.94
Price-Earnings ratio-7.94
Dividend yield—
Dividend yield—
Average volume733.39K
Average volume733.39K
High today$34.50
High today$34.50
Low today$30.86
Low today$30.86
Open price$32.18
Open price$32.18
Volume338.89K
Volume338.89K
52 Week high$34.50
52 Week high$34.50
52 Week low$5.83
52 Week low$5.83
Stock Snapshot
As of today, Zenas BioPharma(ZBIO) shares are valued at $34.50. The company's market cap stands at 1.41B, with a P/E ratio of -7.94.
As of 2025-11-08, Zenas BioPharma(ZBIO) stock has fluctuated between $30.86 and $34.50. The current price stands at $34.50, placing the stock +11.8% above today's low and 0.0% off the high.
The Zenas BioPharma(ZBIO)'s current trading volume is 338.89K, compared to an average daily volume of 733.39K.
In the last year, Zenas BioPharma(ZBIO) shares hit a 52-week high of $34.50 and a 52-week low of $5.83.
In the last year, Zenas BioPharma(ZBIO) shares hit a 52-week high of $34.50 and a 52-week low of $5.83.
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own ZBIO. This list is generated using Robinhood data, and it’s not a recommendation.